Commercialization of novel Diagnostic Platform with Synaptic adaptation Arc treatment method for tinnitus patients.

Informazioni relative al progetto

Tinnitus Platform

ID dell’accordo di sovvenzione: 761940

DOI

10.3030/761940

Progetto chiuso

Data della firma CE 29 Gennaio 2017

Data di avvio 1 Febbraio 2017

Data di completamento 31 Maggio 2017

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale

€ 71 429,00

Contributo UE

€ 50 000,00

Coordinato da

KINETIC CENTRUM NOWOCZESNEJ AUDIOLOGII SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA
Poland

Periodic Reporting for period 1 - Tinnitus Platform (Commercialization of novel Diagnostic Platform with Synaptic adaptation Arc treatment method for tinnitus patients.)

Periodo di rendicontazione: 2017-02-01 al 2017-05-31

Sintesi del contesto e degli obiettivi generali del progetto

Meeting demand for the first medical device for diagnosis and therapy of tinnitus is set to be a crucial challenge for future audiology and neurology. For that reason Kinetic Center of Advanced Audiology (www.kinetic-cna.pl/) aims to commercialize technologies for the Tinnitus examination and treatment. To do so, co-founders rely on their extensive experience and the interdisciplinary team of: audiologists, laryngologists, medical technicians, neurobiologists, neuroscientists, musical trainers, hearing care professionals, clinicians and nutritionists.
Our main objective today is to bring to the global market a novel “Tinnitus Diagnostic Platform” which is a IT platform of multiple test, that can give more information and indicate with more precision the nature of the tinnitus and “Synaptic adaptation Arc therapy” which is dedicated for tinnitus patients after sudden hearing loss.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

The conducted technology and market analysis demonstrated the viability of the technology to reach the market. We performed analysis of competitive solutions, conducted IPR analysis, identified collaborators and elaborated initial work plan for Phase 2.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

The key market application of Tinnitus Diagnostic Platform is to differentiate the pathology of hearing and finally to select appropriate treatment. Synaptic adaptation Arc therapy is based on continuous acoustic stimulation which enforces activity of hear cells and nervous system and gives opportunity to release Arc/Arg 3.1 protein that rebuild synapses. The project addresses the problem of lack of medical device for tinnitus diagnosis and very poor research on the course of the condition.
Finally, to fully exploit and to commercialize this new and EU-based technology, we want to open new Advanced Audiology Clinics around Europe to propose complex methods on hearing pathologies. The Future growth will be driven through sales of Tinnitus Diagnostic Platform to other Audiology Clinics (B2B) and sales of Synaptic adaptation Arc therapy treatment set to patients (B2C).

Tinnitus Platform